Abstract
Introduction: Knowledge of the impact of smoking on health care costs is important for establishing the external effects of smoking and for evaluating policies intended to modify this behavior. Conventional analysis of this association is difficult because of omitted variable bias, reverse causality, and measurement error.
Aims and Methods: We approached these challenges using a Mendelian Randomization study design; genetic variants associated with smoking behaviors were used in instrumental variables models with inpatient hospital costs (calculated from electronic health records) as the outcome. We undertook genome-wide association studies to identify genetic variants associated with smoking initiation and a composite smoking index (reflecting cumulative health impacts of smoking) on up to 300 045 individuals (mean age: 57 years at baseline, range 39-72 years) in the UK Biobank. We followed individuals up for a mean of 6 years.
Results: Genetic liability to initiate smoking (ever vs. never smoking) was estimated to increase mean per-patient annual inpatient hospital costs by £477 (95% confidence interval (CI): £187 to £766). A one-unit change in genetic liability to the composite smoking index (range: 0-4.0) increased inpatient hospital costs by £204 (95% CI: £105 to £303) per unit increase in this index. There was some evidence that the composite smoking index causal models violated the instrumental variable assumptions, and all Mendelian Randomization models were estimated with considerable uncertainty. Models conditioning on risk tolerance were not robust to weak instrument bias.
Conclusions: Our findings have implications for the potential cost-effectiveness of smoking interventions. Implications: We report the first Mendelian Randomization analysis of the causal effect of smoking on health care costs. Using two smoking phenotypes, we identified substantial impacts of smoking on inpatient hospital costs, although the causal models were associated with considerable uncertainty. These results could be used alongside other evidence on the impact of smoking to evaluate the cost-effectiveness of antismoking interventions and to understand the scale of externalities associated with this behavior.
| Original language | English |
|---|---|
| Pages (from-to) | 1521-1529 |
| Number of pages | 9 |
| Journal | Nicotine and Tobacco Research |
| Volume | 26 |
| Issue number | 11 |
| Early online date | 17 Apr 2024 |
| DOIs | |
| Publication status | Published - 1 Nov 2024 |
Data Availability Statement
The UK Biobank data may be made available to researchers following application to its data access committee. Analysis code used in this paper is available at www.github.com/pdixon-econ/MR_smoking_costs.Acknowledgements
This research was conducted using the UK Biobank resource under Application Number 29294 and Application Number 9142.Funding
PD, HMS, GDS, MM, and LDH are members of the MRC Integrative Epidemiology Unit at the University of Bristol which is supported by the Medical Research Council and the University of Bristol (MC_UU_00011/1, MC_UU_00011/7). PD acknowledges support from a Medical Research Council Skills Development Fellowship (MR/P014259/1). HMS is supported by the European Research Council (Reference: 758813 MHINT). LDH was supported by Health Foundation grant “Social and economic consequences of health status - Causal inference methods and longitudinal, intergenerational data,” awarded under the Social and Economic Value of Health programme (Award reference 807293) and a Career Development Award from the UK Medical Research Council (MR/M020894/1).
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Mendelian Randomization Analysis of the Causal Effect of Cigarette Smoking on Hospital Costs'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS